Loading...

Intracellular Staining Permeabilization Wash Buffer (10X) Intracellular Staining Permeabilization Wash Buffer (10X)

Pricing & Availability
Regulatory Status
RUO
Other Names
Perm/Wash, Permeabilization Buffer
Ave. Rating
Submit a Review
Product Citations
publications
Cat # Size Price Quantity Check Availability Save
421002 100 mL DKK559
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Intracellular Staining Permeabilization Wash Buffer is useful for intracellular staining procedures, e.g., in preparation of cells for staining intracellular cytokines or other proteins. Intracellular Staining Permeabilization Wash Buffer is used to permeabilize cells following fixation with Intracellular Staining Fixation Buffer (Cat. No. 420801). It is supplied as a 10X solution and should be diluted in deionized water prior to use. Intracellular Staining Permeabilization Wash Buffer has been formulated to have minimal effects on cells, reduce non-specific staining and enhance the signal to noise ratio. It can be used for antibody dilutions and cell washing during intracellular staining.

Product Details
Technical Data Sheet (pdf)

Product Details

Storage & Handling
The Intracellular Staining Perm wash buffer solution should be stored between 2°C and 8°C. Do not freeze.
Application

ICC, ICFC - Quality tested
IHC - Reported in the literature, not verified in house
Recommended Usage

For use in permeabilization, dilute Intracellular Staining Permeabilization Wash Buffer (10X) to 1X in DI water. Resuspend fixed cells in diluted Intracellular Staining Permeabilization Wash Buffer and centrifuge at 350 xg for 5-10 minutes, and repeat the process twice. It is recommended that the reagent be titrated for optimal performance for each application. Please see "Intracellular Cytokine Staining Protocol" on BioLegend's website for more details.

Application Notes

The Intracellular Staining Permeabilization Wash Buffer (10X) may have crystallization or precipitation observed when it is stored at 2-8°C; however, this is normal and does not affect the buffer's performance. If there is heavy precipitation observed after dilution to 1X working solution, the buffer can be filtered to clarify the solution.

Application References
  1. Smeltz RB. 2007. J. Immunol. 178:4786.
  2. Kang YJ, et al. 2007. Nature Immunol. 8:601.
  3. del Rio ML, et al. 2011. Transplantation. 92:1085. PubMed
  4. del Rio ML, et al. 2012. J. Immunol. 188:4885. PubMed
  5. Marongiu L, et al. 2013. PLoS One. 8:75684. PubMed
  6. Xiao Z, et al. 2013. Mol Immunol. 56:423. PubMed
  7. Kusner LL, et al. 2014. PLoS One. 9:102231. PubMed
  8. Ni PP, et al. 2014. J Immunol. 193:1778. PubMed
Product Citations
  1. Zhuo Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  2. Chen R, et al. 2022. J Mol Cell Biol. 14:. PubMed
  3. Tang J, et al. 2022. Sci Immunol. 7:eadd4853. PubMed
  4. Shen M, et al. 2022. Adv Sci (Weinh). 9:e2203523. PubMed
  5. Hajnik RL, et al. 2022. Sci Transl Med. 14:eabq1945. PubMed
  6. Frost JN, et al. 2022. Sci Adv. 8:eabq5384. PubMed
  7. Li L, et al. 2022. Cancer Immunol Res. 10:1475. PubMed
  8. Deák P, et al. 2022. Cell Rep. 41:111563. PubMed
  9. Stokes JV, et al. 2022. Curr Protoc. 2:e584. PubMed
  10. Jia DJ, et al. 2022. Gut Microbes. 14:2145843. PubMed
  11. Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed
  12. Kodama N, et al. 2023. Front Nutr. 10:1081263. PubMed
  13. Mohamed GA, et al. 2023. Breast Cancer Res. 25:23. PubMed
  14. Varun K, et al. 2023. EBioMedicine. 90:104516. PubMed
  15. Wang YH, et al. 2023. Int J Mol Sci. 24:. PubMed
  16. Deng G, et al. 2023. Cancers (Basel). 15:. PubMed
  17. Wang Y, et al. 2023. iScience. 26:106630. PubMed
  18. Changsheng H, et al. 2023. Sci Adv. 9:eade4186. PubMed
  19. Ruan H, et al. 2023. Acta Pharm Sin B. 13:2202. PubMed
  20. Zhang TR, et al. 2023. Pharmaceuticals (Basel). 16:. PubMed
  21. Komoto S, et al. 2023. Cancers (Basel). 15:. PubMed
  22. Li B, Schmidt N 2016. PLoS One. 11: 0162427. PubMed
  23. Darzianiazizi M, et al. 2020. Int J Mol Sci. 21:00. PubMed
  24. Kim S, et al. 2020. Development. 147:00:00. PubMed
  25. Dumauthioz N, et al. 2020. Cell Mol Immunol. . PubMed
  26. Rappazzo CG, et al. 2020. bioRxiv. . PubMed
  27. Hanga MP, et al. 2021. Biotechnol Bioeng. 118:3175. PubMed
  28. Arbues A, et al. 2020. PLoS Pathog. 16:e1008312. PubMed
  29. Kim J, et al. 2021. Cytometry A. 99:807. PubMed
  30. Sulaj A, et al. 2022. J Clin Endocrinol Metab. 107:2167. PubMed
  31. Brog RA, et al. 2022. Cancer Immunol Res. 10:962. PubMed
  32. Nozaki K, et al. 2022. Nature. 606:960. PubMed
  33. Shemesh A, et al. 2022. J Exp Med. 219: . PubMed
  34. Yin XY, et al. 2023. Neural Regen Res. 18:213. PubMed
  35. Blanas A, et al. 2022. iScience. 25:104719. PubMed
  36. Bates TA, et al. 2022. Cell Rep. 41:111544. PubMed
  37. Gong YY, et al. 2022. Cancer Res Commun. 2:842. PubMed
  38. Liang Y, et al. 2022. Theranostics. 12:7729. PubMed
  39. Wang Y, et al. 2022. Front Endocrinol (Lausanne). 13:1036517. PubMed
  40. Koutník J, et al. 2022. Front Immunol. 13:1049033. PubMed
  41. Minott JA, et al. 2022. Front Immunol. 13:1038340. PubMed
  42. Tan TCJ, et al. 2022. Nat Commun. 13:7796. PubMed
  43. Phares TW, et al. 2022. Front Pharmacol. 13:1029636. PubMed
  44. Zhao X, et al. 2022. STAR Protoc. 3:101859. PubMed
  45. Chan L, et al. 2022. Cells. 12: . PubMed
  46. Ding D, et al. 2023. J Med Chem. 66:1467. PubMed
  47. Qin S, et al. 2023. Acta Pharm Sin B. :. PubMed
  48. Sun L, et al. 2023. Mol Med Rep. 27: . PubMed
  49. Di Benedetto C, et al. 2023. Cancers (Basel). 15: . PubMed
  50. Chan L, et al. 2023. Int J Mol Sci. 24: . PubMed
  51. Xiao JF, et al. 2022. Mol Cancer Res. 20:637. PubMed
  52. Shen JZ, et al. 2022. Mol Cell. 82:1123. PubMed
  53. Guo H, et al. 2022. Biomaterials. 283:121441. PubMed
  54. Zhang H, et al. 2022. J Exp Med. 219:. PubMed
  55. Bronge M, et al. 2022. Sci Adv. 8:eabn1823. PubMed
  56. Lentucci C, et al. 2017. J Biol Chem. 292:2754-2772. PubMed
  57. Glaser K, et al. 2015. Immunol Lett. 166: 19-27. PubMed
  58. Kusner L, et al. 2014. PLoS One. 9:102231. PubMed
  59. Khayrullina G, et al. 2020. Skelet Muscle. 10:16. PubMed
  60. Spitzer SO, et al. 2019. Neuron. 101:459. PubMed
  61. Li L,et al. 2017. Sci Rep.. 10.1038/s41598-017-14000-z. PubMed
  62. Li Q, et al. 2022. Cell Rep. 40:111308. PubMed
  63. van Vloten JP, et al. 2022. J Immunother Cancer. 10:. PubMed
  64. Lebedeva IV, et al. 2021. Cell Death Dis. 12:770. PubMed
  65. Zhang L, et al. 2021. J Immunol. 207:590. PubMed
  66. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  67. Zhang Y, et al. 2020. Oncol Lett. 1.053472222. PubMed
  68. Stewart CA, et al. 2020. bioRxiv. . PubMed
  69. Huang X, et al. 2019. Cancer Immunol Res. 1.388888889. PubMed
  70. Angiari S, et al. 2020. Cell Metab. 31:391. PubMed
  71. Jacob A, et al. 2020. Nature Protocols. 14(12):3303-3332.. PubMed
  72. Stewart CA, et al. 2021. J Thorac Oncol. Online ahead of prin. PubMed
  73. Kiritsy MC, et al. 2021. Elife. 10:. PubMed
  74. Poli V, et al. 2021. iScience. 24:103256. PubMed
  75. Duan Q, et al. 2021. Front Cell Dev Biol. 9:761193. PubMed
  76. Stegelmeier AA, et al. 2022. Biomedicines. 10:. PubMed
  77. Zhang S, et al. 2022. Cell Death Dis. 13:844. PubMed
  78. Haque M, et al. 2021. STAR Protoc. 2:100264. PubMed
  79. Martinez-Usatorre A, et al. 2020. Front Immunol. 11:340. PubMed
  80. Martinez–Usatorre A, et al. 2019. Cancer Immunol Res. 0.995138889. PubMed
  81. Goyal S, et al. 2017. Sci Rep. . 10.1038/s41598-017-18046-x. PubMed
  82. Tsai CY, et al. 2022. J Biomed Sci. 29:47. PubMed
  83. Gärtner F, et al. 2021. Front Immunol. 12:745132. PubMed
  84. Gao F, et al. 2021. Front Cell Infect Microbiol. 10:593805. PubMed
  85. Tang B, et al. 2020. Clin Cancer Res. 26:2216. PubMed
  86. Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed
  87. Eslani M,et al. 2017. Invest Ophthalmol Vis Sci.. 58(12):5507-5517. PubMed
  88. Shinde MY, et al. 2017. J Biol Chem. 292:18240. PubMed
  89. Haryadi L, et al. 2019. Vet World. 12:1529. PubMed
  90. Ghose J, et al. 2018. Oncoimmunology. 7:e1486948. PubMed
  91. Herda S, et al. 2021. Int J Cancer. 148:3097. PubMed
  92. Lau H, et al. 2021. Int J Mol Sci. 22:. PubMed
  93. Zhou H, et al. 2022. J Clin Invest. 132:. PubMed
  94. Zhang X, et al. 2020. J Immunol. 205:1743. PubMed
  95. Ni P, et al. 2014. J Immunol . 193:1778. PubMed
  96. Sohrabi Y, et al. 2020. Front Immunol. 11:353. PubMed
  97. Martinez–Usatorre A, et al. 2018. J Immunol. 201:792. PubMed
  98. Subham S, et al. 2022. Breast Cancer Res Treat. Online ahead of print. PubMed
  99. Lau H, et al. 2021. Xenotransplantation. 28:e12667. PubMed
  100. Su W, et al. 2022. Front Immunol. 13:952338. PubMed
  101. Ma Q, et al. 2022. Nat Commun. 13:4142. PubMed
  102. Datta A, et al. 2022. J Fungi (Basel). 8:. PubMed
  103. Jiang P, et al. 2021. Nat Methods. 18:1181. PubMed
  104. Zhan Y, et al. 2021. JCI Insight. 6:. PubMed
  105. Hendricks A, et al. 2021. Front Oncol. 11:646885. PubMed
  106. Shamsi F, et al. 2021. Nat Metab. 3:485. PubMed
  107. Xiao Z, et al. 2013. Mol Immunol. 56:423. PubMed
  108. Hilpert C, et al. 2016. J Immunol. 197: 2780 - 2786. PubMed
  109. Clancy–Thompson E, et al. 2018. Cancer Immunol Res. 1.308333333. PubMed
  110. Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed
  111. Zhang X, et al. 2022. Theranostics. 12:1621. PubMed
  112. Berical A, et al. 2022. Nat Commun. 13:4270. PubMed
  113. Pearce V, et al. 2015. J Immunol. 195: 3206 - 3217. PubMed
  114. Baek J, et al. 2017. Am J Pathol. 10.1016/j.ajpath.2017.02.011. PubMed
  115. Zhang L, et al. 2021. Methods Mol Biol. 2388:175. PubMed
  116. Rodriguez S, et al. 2020. Xenotransplantation. 27:e12554. PubMed
  117. Chakraborty S, et al. 2022. Sci Transl Med. . PubMed
  118. Leonard NA, et al. 2021. Cancers (Basel). 13:. PubMed
  119. Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed
  120. Lownik JC, et al. 2019. J Immunol. 202:664. PubMed
  121. Lau H, et al. 2020. Xenotransplantation. 27:e12555. PubMed
  122. Mkhikian H, et al. 2022. Nat Aging. 2:231. PubMed
  123. Li J, et al. 2022. J Tissue Eng. 13:20417314221127908. PubMed
  124. Ouyang W, et al. 2021. Invest Ophthalmol Vis Sci. 62:25:00. PubMed
  125. Nausch N, et al. 2017. PLoS Negl Trop Dis. 11(2):e0005415. PubMed
  126. Xu Z, et al. 2016. Nat Commun. 7:10728. PubMed
  127. Breznik JA, et al. 2018. Physiol Rep. 6:e13937. PubMed
  128. Ren Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  129. Wei W, et al. 2022. mSystems. 7:e0046922. PubMed
  130. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  131. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  132. Alvandi Z, et al. 2022. J Am Heart Assoc. 11:e023695. PubMed
  133. van Duijn A, et al. 2021. Cancer Immunol Immunother. Online ahead of print. PubMed
  134. Jakic B, et al. 2021. Cell Death Dis. 12:187. PubMed
  135. Li Q, et al. 2017. Front Immunol. 0.797916667. PubMed
  136. Page N, et al. 2021. Nat Commun. 12:1009. PubMed
  137. Gunasena M, et al. 2022. Sci Rep. 12:12377. PubMed
  138. Liu X, et al. 2016. Sci Rep. 6:36722. PubMed
  139. Rio M, et al. 2012. J Immunol. 188:4885. PubMed
  140. Kundu K, et al. 2019. Cancer Immunol Res. 1.069444444. PubMed
  141. Bajpai G, et al. 2018. Nat Med. 24:1234. PubMed
  142. Janela B, et al. 2019. Immunity. 50:1069. PubMed
  143. Wilmes A, et al. 2017. Toxicol In Vitro. 10.1016/j.tiv.2017.07.023. PubMed
  144. Hayes D, et al. 2022. JCI Insight. 7:. PubMed
  145. Gong C, et al. 2021. Mol Cell. 81:4059. PubMed
  146. Chen DL, et al. 2021. Mol Cancer. 20:166. PubMed
  147. Kim S, et al. 2020. Development. . PubMed
  148. Henrich IC, et al. 2021. Cancer Res. 81:2171. PubMed
  149. Rio M, et al. 2011. Transplantation. 92:1085. PubMed
  150. Chen YF, et al. 2019. J Biomed Sci. 26:85. PubMed
  151. Hiza H, et al. 2021. Sci Rep. 11:13190. PubMed
  152. Wen T, et al. 2022. Cancer Immunol Res. 10:162. PubMed
  153. Ma K, et al. 2022. iScience. 25:104347. PubMed
  154. Wang Y, et al. 2020. Virol Sin. 36:122. PubMed
  155. Lau H, et al. 2020. Islets. 41:12. PubMed
  156. Lau H, et al. 2020. PLoS One. 15:e0243506. PubMed
  157. Wang G, et al. 2020. Nat Commun. 0.611111111. PubMed
  158. Dong M, et al. 2022. J Immunother Cancer. 10:. PubMed
  159. Shemesh A, et al. 2022. J Exp Med. 219:. PubMed
  160. Teh MR, et al. 2021. Front Immunol. 12:714613. PubMed
  161. Haswell JR, et al. 2021. PLoS One. 16:e0252848. PubMed
  162. Park SR, et al. 2020. Cell Rep. 32:108077. PubMed
  163. Ansari M, et al. 2017. Cell Signal. 10.1016/j.cellsig.2017.04.014. PubMed
  164. Ahmad S, et al. 2017. Prog Neuropsychopharmacol Biol Psychiatry. 10.1016/j.pnpbp.2017.06.034. PubMed
  165. Xia Y, et al. 2018. Cell. 175:1059. PubMed
  166. Chen RH, et al. 2021. Front Immunol. 11:594775. PubMed
  167. Spiliopoulou P, et al. 2022. Mol Cancer Ther. . PubMed
  168. Tintos-Hernandez JA, et al. 2021. Brain Commun. 3:fcab215. PubMed
  169. Koutník J, et al. 2022. Cell Commun Signal. 20:54. PubMed
  170. Zhao X, et al. 2022. iScience. 25:104690. PubMed
  171. Cérbulo-Vázquez A, et al. 2022. PLoS One. 17:e0264566. PubMed
  172. Gao J, et al. 2022. Front Immunol. 13:955812. PubMed
  173. Lei L, et al. 2021. Front Cell Dev Biol. 659744:9. PubMed
  174. Frafjord A, et al. 2020. Scand J Immunol. e12889:92. PubMed
  175. Lownik JC, et al. 2020. Biochem Biophys Rep. 24:100803. PubMed
  176. Labi V, et al. 2019. Genes Dev. 33:1673. PubMed
  177. Sun X, et al. 2017. Microbes Infect. 10.1016/j.micinf.2017.08.007. PubMed
  178. Rhoades NS, et al. 2022. Cell Rep. 39:110725. PubMed
  179. Reuschl AK, et al. 2022. Cell Rep. 39:110650. PubMed
  180. Tatangelo V, et al. 2022. Front Oncol. 12:877495. PubMed
  181. Huang T, et al. 2022. Nat Commun. 13:3489. PubMed
  182. Deng Y, et al. 2021. Nat Commun. 12:7041. PubMed
  183. DiMuzio JM, et al. 2021. Vaccine X. 8:100098. PubMed
  184. Lee G, et al. 2021. Viruses. 13: . PubMed
  185. Hernandez AA, et al. 2020. J Immunol. 205:2806. PubMed
  186. Su Y, et al. 2020. Cell. 1479:183. PubMed
  187. Wawrzyniak M, et al. 2021. Pharmacol Res Perspect. 9:e00837. PubMed
  188. Mcgaw C, et al. 2022. Nat Commun. 13:2833. PubMed
  189. Wagner AK, et al. 2022. iScience. 25:105137. PubMed
  190. Zheng L, et al. 2020. Clin Cancer Res. 26:3694. PubMed
  191. Witt G, et al. 2020. Cell Biol Toxicol. . PubMed
  192. Marongiu L, et al. 2013. PLoS One. 8:75684. PubMed
  193. Giadone RM, et al. 2018. Amyloid. 25:148. PubMed
  194. Gebremeskel S, et al. 2017. Cancer Immunol Res. 0.9625. PubMed
  195. Sun Y, et al. 2022. iScience. 25:104846. PubMed
  196. van Loon K, et al. 2022. Cancers (Basel). 14:. PubMed
  197. Wang X, et al. 2022. Elife. 11:. PubMed
  198. Liu X, et al. 2021. Adv Sci (Weinh). 8:e2100233. PubMed
  199. Heckler M, et al. 2021. Cancer Discov. Online ahead of prin. PubMed
  200. Zhang Z, et al. 2021. Front Immunol. 12:699478. PubMed
  201. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  202. Chen Y, et al. 2021. Braz J Med Biol Res. 54:e9570. PubMed
  203. Xiao C, et al. 2021. STAR Protoc. 2:100789. PubMed
  204. Chen S, et al. 2020. Cancer Immunol Res. 1064:8. PubMed
  205. Assadi G, et al. 2016. PLoS One. 11:e0168276. PubMed
  206. Ikebuchi R, et al. 2016. Sci Rep. 6:35002. PubMed
  207. Lei F, et al. 2012. J Vis Exp. 63: 3986. PubMed
  208. Guo Z, et al. 2022. Neurobiol Pain. 12:100096. PubMed
  209. Luvanda MK, et al. 2021. J Fungi (Basel). 7:. PubMed
  210. Zhuo Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  211. Chen R, et al. 2022. J Mol Cell Biol. 14:. PubMed
  212. Tang J, et al. 2022. Sci Immunol. 7:eadd4853. PubMed
  213. Shen M, et al. 2022. Adv Sci (Weinh). 9:e2203523. PubMed
  214. Hajnik RL, et al. 2022. Sci Transl Med. 14:eabq1945. PubMed
  215. Frost JN, et al. 2022. Sci Adv. 8:eabq5384. PubMed
  216. Li L, et al. 2022. Cancer Immunol Res. 10:1475. PubMed
  217. Deák P, et al. 2022. Cell Rep. 41:111563. PubMed
  218. Stokes JV, et al. 2022. Curr Protoc. 2:e584. PubMed
  219. Jia DJ, et al. 2022. Gut Microbes. 14:2145843. PubMed
  220. Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed
  221. Kodama N, et al. 2023. Front Nutr. 10:1081263. PubMed
  222. Mohamed GA, et al. 2023. Breast Cancer Res. 25:23. PubMed
  223. Varun K, et al. 2023. EBioMedicine. 90:104516. PubMed
  224. Wang YH, et al. 2023. Int J Mol Sci. 24:. PubMed
  225. Deng G, et al. 2023. Cancers (Basel). 15:. PubMed
  226. Wang Y, et al. 2023. iScience. 26:106630. PubMed
  227. Changsheng H, et al. 2023. Sci Adv. 9:eade4186. PubMed
  228. Ruan H, et al. 2023. Acta Pharm Sin B. 13:2202. PubMed
  229. Zhang TR, et al. 2023. Pharmaceuticals (Basel). 16:. PubMed
  230. Komoto S, et al. 2023. Cancers (Basel). 15:. PubMed
  231. Li B, Schmidt N 2016. PLoS One. 11: 0162427. PubMed
  232. Darzianiazizi M, et al. 2020. Int J Mol Sci. 21:00. PubMed
  233. Kim S, et al. 2020. Development. 147:00:00. PubMed
  234. Dumauthioz N, et al. 2020. Cell Mol Immunol. . PubMed
  235. Rappazzo CG, et al. 2020. bioRxiv. . PubMed
  236. Hanga MP, et al. 2021. Biotechnol Bioeng. 118:3175. PubMed
  237. Arbues A, et al. 2020. PLoS Pathog. 16:e1008312. PubMed
  238. Kim J, et al. 2021. Cytometry A. 99:807. PubMed
  239. Sulaj A, et al. 2022. J Clin Endocrinol Metab. 107:2167. PubMed
  240. Brog RA, et al. 2022. Cancer Immunol Res. 10:962. PubMed
  241. Nozaki K, et al. 2022. Nature. 606:960. PubMed
  242. Shemesh A, et al. 2022. J Exp Med. 219: . PubMed
  243. Yin XY, et al. 2023. Neural Regen Res. 18:213. PubMed
  244. Blanas A, et al. 2022. iScience. 25:104719. PubMed
  245. Bates TA, et al. 2022. Cell Rep. 41:111544. PubMed
  246. Gong YY, et al. 2022. Cancer Res Commun. 2:842. PubMed
  247. Liang Y, et al. 2022. Theranostics. 12:7729. PubMed
  248. Wang Y, et al. 2022. Front Endocrinol (Lausanne). 13:1036517. PubMed
  249. Koutník J, et al. 2022. Front Immunol. 13:1049033. PubMed
  250. Minott JA, et al. 2022. Front Immunol. 13:1038340. PubMed
  251. Tan TCJ, et al. 2022. Nat Commun. 13:7796. PubMed
  252. Phares TW, et al. 2022. Front Pharmacol. 13:1029636. PubMed
  253. Zhao X, et al. 2022. STAR Protoc. 3:101859. PubMed
  254. Chan L, et al. 2022. Cells. 12: . PubMed
  255. Ding D, et al. 2023. J Med Chem. 66:1467. PubMed
  256. Qin S, et al. 2023. Acta Pharm Sin B. :. PubMed
  257. Sun L, et al. 2023. Mol Med Rep. 27: . PubMed
  258. Di Benedetto C, et al. 2023. Cancers (Basel). 15: . PubMed
  259. Chan L, et al. 2023. Int J Mol Sci. 24: . PubMed
  260. Xiao JF, et al. 2022. Mol Cancer Res. 20:637. PubMed
  261. Shen JZ, et al. 2022. Mol Cell. 82:1123. PubMed
  262. Guo H, et al. 2022. Biomaterials. 283:121441. PubMed
  263. Zhang H, et al. 2022. J Exp Med. 219:. PubMed
  264. Bronge M, et al. 2022. Sci Adv. 8:eabn1823. PubMed
  265. Lentucci C, et al. 2017. J Biol Chem. 292:2754-2772. PubMed
  266. Glaser K, et al. 2015. Immunol Lett. 166: 19-27. PubMed
  267. Kusner L, et al. 2014. PLoS One. 9:102231. PubMed
  268. Khayrullina G, et al. 2020. Skelet Muscle. 10:16. PubMed
  269. Spitzer SO, et al. 2019. Neuron. 101:459. PubMed
  270. Li L,et al. 2017. Sci Rep.. 10.1038/s41598-017-14000-z. PubMed
  271. Li Q, et al. 2022. Cell Rep. 40:111308. PubMed
  272. van Vloten JP, et al. 2022. J Immunother Cancer. 10:. PubMed
  273. Lebedeva IV, et al. 2021. Cell Death Dis. 12:770. PubMed
  274. Zhang L, et al. 2021. J Immunol. 207:590. PubMed
  275. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  276. Zhang Y, et al. 2020. Oncol Lett. 1.053472222. PubMed
  277. Stewart CA, et al. 2020. bioRxiv. . PubMed
  278. Huang X, et al. 2019. Cancer Immunol Res. 1.388888889. PubMed
  279. Angiari S, et al. 2020. Cell Metab. 31:391. PubMed
  280. Jacob A, et al. 2020. Nature Protocols. 14(12):3303-3332.. PubMed
  281. Stewart CA, et al. 2021. J Thorac Oncol. Online ahead of prin. PubMed
  282. Kiritsy MC, et al. 2021. Elife. 10:. PubMed
  283. Poli V, et al. 2021. iScience. 24:103256. PubMed
  284. Duan Q, et al. 2021. Front Cell Dev Biol. 9:761193. PubMed
  285. Stegelmeier AA, et al. 2022. Biomedicines. 10:. PubMed
  286. Zhang S, et al. 2022. Cell Death Dis. 13:844. PubMed
  287. Haque M, et al. 2021. STAR Protoc. 2:100264. PubMed
  288. Martinez-Usatorre A, et al. 2020. Front Immunol. 11:340. PubMed
  289. Martinez–Usatorre A, et al. 2019. Cancer Immunol Res. 0.995138889. PubMed
  290. Goyal S, et al. 2017. Sci Rep. . 10.1038/s41598-017-18046-x. PubMed
  291. Tsai CY, et al. 2022. J Biomed Sci. 29:47. PubMed
  292. Gärtner F, et al. 2021. Front Immunol. 12:745132. PubMed
  293. Gao F, et al. 2021. Front Cell Infect Microbiol. 10:593805. PubMed
  294. Tang B, et al. 2020. Clin Cancer Res. 26:2216. PubMed
  295. Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed
  296. Eslani M,et al. 2017. Invest Ophthalmol Vis Sci.. 58(12):5507-5517. PubMed
  297. Shinde MY, et al. 2017. J Biol Chem. 292:18240. PubMed
  298. Haryadi L, et al. 2019. Vet World. 12:1529. PubMed
  299. Ghose J, et al. 2018. Oncoimmunology. 7:e1486948. PubMed
  300. Herda S, et al. 2021. Int J Cancer. 148:3097. PubMed
  301. Lau H, et al. 2021. Int J Mol Sci. 22:. PubMed
  302. Zhou H, et al. 2022. J Clin Invest. 132:. PubMed
  303. Zhang X, et al. 2020. J Immunol. 205:1743. PubMed
  304. Ni P, et al. 2014. J Immunol . 193:1778. PubMed
  305. Sohrabi Y, et al. 2020. Front Immunol. 11:353. PubMed
  306. Martinez–Usatorre A, et al. 2018. J Immunol. 201:792. PubMed
  307. Subham S, et al. 2022. Breast Cancer Res Treat. Online ahead of print. PubMed
  308. Lau H, et al. 2021. Xenotransplantation. 28:e12667. PubMed
  309. Su W, et al. 2022. Front Immunol. 13:952338. PubMed
  310. Ma Q, et al. 2022. Nat Commun. 13:4142. PubMed
  311. Datta A, et al. 2022. J Fungi (Basel). 8:. PubMed
  312. Jiang P, et al. 2021. Nat Methods. 18:1181. PubMed
  313. Zhan Y, et al. 2021. JCI Insight. 6:. PubMed
  314. Hendricks A, et al. 2021. Front Oncol. 11:646885. PubMed
  315. Shamsi F, et al. 2021. Nat Metab. 3:485. PubMed
  316. Xiao Z, et al. 2013. Mol Immunol. 56:423. PubMed
  317. Hilpert C, et al. 2016. J Immunol. 197: 2780 - 2786. PubMed
  318. Clancy–Thompson E, et al. 2018. Cancer Immunol Res. 1.308333333. PubMed
  319. Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed
  320. Zhang X, et al. 2022. Theranostics. 12:1621. PubMed
  321. Berical A, et al. 2022. Nat Commun. 13:4270. PubMed
  322. Pearce V, et al. 2015. J Immunol. 195: 3206 - 3217. PubMed
  323. Baek J, et al. 2017. Am J Pathol. 10.1016/j.ajpath.2017.02.011. PubMed
  324. Zhang L, et al. 2021. Methods Mol Biol. 2388:175. PubMed
  325. Rodriguez S, et al. 2020. Xenotransplantation. 27:e12554. PubMed
  326. Chakraborty S, et al. 2022. Sci Transl Med. . PubMed
  327. Leonard NA, et al. 2021. Cancers (Basel). 13:. PubMed
  328. Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed
  329. Lownik JC, et al. 2019. J Immunol. 202:664. PubMed
  330. Lau H, et al. 2020. Xenotransplantation. 27:e12555. PubMed
  331. Mkhikian H, et al. 2022. Nat Aging. 2:231. PubMed
  332. Li J, et al. 2022. J Tissue Eng. 13:20417314221127908. PubMed
  333. Ouyang W, et al. 2021. Invest Ophthalmol Vis Sci. 62:25:00. PubMed
  334. Nausch N, et al. 2017. PLoS Negl Trop Dis. 11(2):e0005415. PubMed
  335. Xu Z, et al. 2016. Nat Commun. 7:10728. PubMed
  336. Breznik JA, et al. 2018. Physiol Rep. 6:e13937. PubMed
  337. Ren Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  338. Wei W, et al. 2022. mSystems. 7:e0046922. PubMed
  339. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  340. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  341. Alvandi Z, et al. 2022. J Am Heart Assoc. 11:e023695. PubMed
  342. van Duijn A, et al. 2021. Cancer Immunol Immunother. Online ahead of print. PubMed
  343. Jakic B, et al. 2021. Cell Death Dis. 12:187. PubMed
  344. Li Q, et al. 2017. Front Immunol. 0.797916667. PubMed
  345. Page N, et al. 2021. Nat Commun. 12:1009. PubMed
  346. Gunasena M, et al. 2022. Sci Rep. 12:12377. PubMed
  347. Liu X, et al. 2016. Sci Rep. 6:36722. PubMed
  348. Rio M, et al. 2012. J Immunol. 188:4885. PubMed
  349. Kundu K, et al. 2019. Cancer Immunol Res. 1.069444444. PubMed
  350. Bajpai G, et al. 2018. Nat Med. 24:1234. PubMed
  351. Janela B, et al. 2019. Immunity. 50:1069. PubMed
  352. Wilmes A, et al. 2017. Toxicol In Vitro. 10.1016/j.tiv.2017.07.023. PubMed
  353. Hayes D, et al. 2022. JCI Insight. 7:. PubMed
  354. Gong C, et al. 2021. Mol Cell. 81:4059. PubMed
  355. Chen DL, et al. 2021. Mol Cancer. 20:166. PubMed
  356. Kim S, et al. 2020. Development. . PubMed
  357. Henrich IC, et al. 2021. Cancer Res. 81:2171. PubMed
  358. Rio M, et al. 2011. Transplantation. 92:1085. PubMed
  359. Chen YF, et al. 2019. J Biomed Sci. 26:85. PubMed
  360. Hiza H, et al. 2021. Sci Rep. 11:13190. PubMed
  361. Wen T, et al. 2022. Cancer Immunol Res. 10:162. PubMed
  362. Ma K, et al. 2022. iScience. 25:104347. PubMed
  363. Wang Y, et al. 2020. Virol Sin. 36:122. PubMed
  364. Lau H, et al. 2020. Islets. 41:12. PubMed
  365. Lau H, et al. 2020. PLoS One. 15:e0243506. PubMed
  366. Wang G, et al. 2020. Nat Commun. 0.611111111. PubMed
  367. Dong M, et al. 2022. J Immunother Cancer. 10:. PubMed
  368. Shemesh A, et al. 2022. J Exp Med. 219:. PubMed
  369. Teh MR, et al. 2021. Front Immunol. 12:714613. PubMed
  370. Haswell JR, et al. 2021. PLoS One. 16:e0252848. PubMed
  371. Park SR, et al. 2020. Cell Rep. 32:108077. PubMed
  372. Ansari M, et al. 2017. Cell Signal. 10.1016/j.cellsig.2017.04.014. PubMed
  373. Ahmad S, et al. 2017. Prog Neuropsychopharmacol Biol Psychiatry. 10.1016/j.pnpbp.2017.06.034. PubMed
  374. Xia Y, et al. 2018. Cell. 175:1059. PubMed
  375. Chen RH, et al. 2021. Front Immunol. 11:594775. PubMed
  376. Spiliopoulou P, et al. 2022. Mol Cancer Ther. . PubMed
  377. Tintos-Hernandez JA, et al. 2021. Brain Commun. 3:fcab215. PubMed
  378. Koutník J, et al. 2022. Cell Commun Signal. 20:54. PubMed
  379. Zhao X, et al. 2022. iScience. 25:104690. PubMed
  380. Cérbulo-Vázquez A, et al. 2022. PLoS One. 17:e0264566. PubMed
  381. Gao J, et al. 2022. Front Immunol. 13:955812. PubMed
  382. Lei L, et al. 2021. Front Cell Dev Biol. 659744:9. PubMed
  383. Frafjord A, et al. 2020. Scand J Immunol. e12889:92. PubMed
  384. Lownik JC, et al. 2020. Biochem Biophys Rep. 24:100803. PubMed
  385. Labi V, et al. 2019. Genes Dev. 33:1673. PubMed
  386. Sun X, et al. 2017. Microbes Infect. 10.1016/j.micinf.2017.08.007. PubMed
  387. Rhoades NS, et al. 2022. Cell Rep. 39:110725. PubMed
  388. Reuschl AK, et al. 2022. Cell Rep. 39:110650. PubMed
  389. Tatangelo V, et al. 2022. Front Oncol. 12:877495. PubMed
  390. Huang T, et al. 2022. Nat Commun. 13:3489. PubMed
  391. Deng Y, et al. 2021. Nat Commun. 12:7041. PubMed
  392. DiMuzio JM, et al. 2021. Vaccine X. 8:100098. PubMed
  393. Lee G, et al. 2021. Viruses. 13: . PubMed
  394. Hernandez AA, et al. 2020. J Immunol. 205:2806. PubMed
  395. Su Y, et al. 2020. Cell. 1479:183. PubMed
  396. Wawrzyniak M, et al. 2021. Pharmacol Res Perspect. 9:e00837. PubMed
  397. Mcgaw C, et al. 2022. Nat Commun. 13:2833. PubMed
  398. Wagner AK, et al. 2022. iScience. 25:105137. PubMed
  399. Zheng L, et al. 2020. Clin Cancer Res. 26:3694. PubMed
  400. Witt G, et al. 2020. Cell Biol Toxicol. . PubMed
  401. Marongiu L, et al. 2013. PLoS One. 8:75684. PubMed
  402. Giadone RM, et al. 2018. Amyloid. 25:148. PubMed
  403. Gebremeskel S, et al. 2017. Cancer Immunol Res. 0.9625. PubMed
  404. Sun Y, et al. 2022. iScience. 25:104846. PubMed
  405. van Loon K, et al. 2022. Cancers (Basel). 14:. PubMed
  406. Wang X, et al. 2022. Elife. 11:. PubMed
  407. Liu X, et al. 2021. Adv Sci (Weinh). 8:e2100233. PubMed
  408. Heckler M, et al. 2021. Cancer Discov. Online ahead of prin. PubMed
  409. Zhang Z, et al. 2021. Front Immunol. 12:699478. PubMed
  410. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  411. Chen Y, et al. 2021. Braz J Med Biol Res. 54:e9570. PubMed
  412. Xiao C, et al. 2021. STAR Protoc. 2:100789. PubMed
  413. Chen S, et al. 2020. Cancer Immunol Res. 1064:8. PubMed
  414. Assadi G, et al. 2016. PLoS One. 11:e0168276. PubMed
  415. Ikebuchi R, et al. 2016. Sci Rep. 6:35002. PubMed
  416. Lei F, et al. 2012. J Vis Exp. 63: 3986. PubMed
  417. Guo Z, et al. 2022. Neurobiol Pain. 12:100096. PubMed
  418. Luvanda MK, et al. 2021. J Fungi (Basel). 7:. PubMed

Antigen Details

Antigen References

1. Current Protocols in Immunology (John Wiley & Sons New York) Unit 6.24 Detection of Intracellular Cytokines by Flow Cytometry (Barbara Foster and Calman Prussin NIAID NIH Bethesda MD).
2. Sander B, et al. 1991. Immunol. Rev. 119:65.
3. Sander B, et al. 1993. J. Immunol. Meth. 166:201.
4. Prussin C, et al. 1995. J. Immunol. Meth. 188:117.

Gene ID
NA

Related FAQs

There are no FAQs for this product.
Go To Top Version: 3    Revision Date: 08/26/2015

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

Pricing & Availability
Regulatory Status
RUO
Other Names
Perm/Wash, Permeabilization Buffer
Ave. Rating
Submit a Review
Product Citations
publications
Cat # Size Price Quantity Check Availability Save
421002 100 mL DKK559
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Intracellular Staining Permeabilization Wash Buffer is useful for intracellular staining procedures, e.g., in preparation of cells for staining intracellular cytokines or other proteins. Intracellular Staining Permeabilization Wash Buffer is used to permeabilize cells following fixation with Intracellular Staining Fixation Buffer (Cat. No. 420801). It is supplied as a 10X solution and should be diluted in deionized water prior to use. Intracellular Staining Permeabilization Wash Buffer has been formulated to have minimal effects on cells, reduce non-specific staining and enhance the signal to noise ratio. It can be used for antibody dilutions and cell washing during intracellular staining.

Product Details
Technical Data Sheet (pdf)

Product Details

Storage & Handling
The Intracellular Staining Perm wash buffer solution should be stored between 2°C and 8°C. Do not freeze.
Application

ICC, ICFC - Quality tested
IHC - Reported in the literature, not verified in house
Recommended Usage

For use in permeabilization, dilute Intracellular Staining Permeabilization Wash Buffer (10X) to 1X in DI water. Resuspend fixed cells in diluted Intracellular Staining Permeabilization Wash Buffer and centrifuge at 350 xg for 5-10 minutes, and repeat the process twice. It is recommended that the reagent be titrated for optimal performance for each application. Please see "Intracellular Cytokine Staining Protocol" on BioLegend's website for more details.

Application Notes

The Intracellular Staining Permeabilization Wash Buffer (10X) may have crystallization or precipitation observed when it is stored at 2-8°C; however, this is normal and does not affect the buffer's performance. If there is heavy precipitation observed after dilution to 1X working solution, the buffer can be filtered to clarify the solution.

Application References
  1. Smeltz RB. 2007. J. Immunol. 178:4786.
  2. Kang YJ, et al. 2007. Nature Immunol. 8:601.
  3. del Rio ML, et al. 2011. Transplantation. 92:1085. PubMed
  4. del Rio ML, et al. 2012. J. Immunol. 188:4885. PubMed
  5. Marongiu L, et al. 2013. PLoS One. 8:75684. PubMed
  6. Xiao Z, et al. 2013. Mol Immunol. 56:423. PubMed
  7. Kusner LL, et al. 2014. PLoS One. 9:102231. PubMed
  8. Ni PP, et al. 2014. J Immunol. 193:1778. PubMed
Product Citations
  1. Zhuo Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  2. Chen R, et al. 2022. J Mol Cell Biol. 14:. PubMed
  3. Tang J, et al. 2022. Sci Immunol. 7:eadd4853. PubMed
  4. Shen M, et al. 2022. Adv Sci (Weinh). 9:e2203523. PubMed
  5. Hajnik RL, et al. 2022. Sci Transl Med. 14:eabq1945. PubMed
  6. Frost JN, et al. 2022. Sci Adv. 8:eabq5384. PubMed
  7. Li L, et al. 2022. Cancer Immunol Res. 10:1475. PubMed
  8. Deák P, et al. 2022. Cell Rep. 41:111563. PubMed
  9. Stokes JV, et al. 2022. Curr Protoc. 2:e584. PubMed
  10. Jia DJ, et al. 2022. Gut Microbes. 14:2145843. PubMed
  11. Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed
  12. Kodama N, et al. 2023. Front Nutr. 10:1081263. PubMed
  13. Mohamed GA, et al. 2023. Breast Cancer Res. 25:23. PubMed
  14. Varun K, et al. 2023. EBioMedicine. 90:104516. PubMed
  15. Wang YH, et al. 2023. Int J Mol Sci. 24:. PubMed
  16. Deng G, et al. 2023. Cancers (Basel). 15:. PubMed
  17. Wang Y, et al. 2023. iScience. 26:106630. PubMed
  18. Changsheng H, et al. 2023. Sci Adv. 9:eade4186. PubMed
  19. Ruan H, et al. 2023. Acta Pharm Sin B. 13:2202. PubMed
  20. Zhang TR, et al. 2023. Pharmaceuticals (Basel). 16:. PubMed
  21. Komoto S, et al. 2023. Cancers (Basel). 15:. PubMed
  22. Li B, Schmidt N 2016. PLoS One. 11: 0162427. PubMed
  23. Darzianiazizi M, et al. 2020. Int J Mol Sci. 21:00. PubMed
  24. Kim S, et al. 2020. Development. 147:00:00. PubMed
  25. Dumauthioz N, et al. 2020. Cell Mol Immunol. . PubMed
  26. Rappazzo CG, et al. 2020. bioRxiv. . PubMed
  27. Hanga MP, et al. 2021. Biotechnol Bioeng. 118:3175. PubMed
  28. Arbues A, et al. 2020. PLoS Pathog. 16:e1008312. PubMed
  29. Kim J, et al. 2021. Cytometry A. 99:807. PubMed
  30. Sulaj A, et al. 2022. J Clin Endocrinol Metab. 107:2167. PubMed
  31. Brog RA, et al. 2022. Cancer Immunol Res. 10:962. PubMed
  32. Nozaki K, et al. 2022. Nature. 606:960. PubMed
  33. Shemesh A, et al. 2022. J Exp Med. 219: . PubMed
  34. Yin XY, et al. 2023. Neural Regen Res. 18:213. PubMed
  35. Blanas A, et al. 2022. iScience. 25:104719. PubMed
  36. Bates TA, et al. 2022. Cell Rep. 41:111544. PubMed
  37. Gong YY, et al. 2022. Cancer Res Commun. 2:842. PubMed
  38. Liang Y, et al. 2022. Theranostics. 12:7729. PubMed
  39. Wang Y, et al. 2022. Front Endocrinol (Lausanne). 13:1036517. PubMed
  40. Koutník J, et al. 2022. Front Immunol. 13:1049033. PubMed
  41. Minott JA, et al. 2022. Front Immunol. 13:1038340. PubMed
  42. Tan TCJ, et al. 2022. Nat Commun. 13:7796. PubMed
  43. Phares TW, et al. 2022. Front Pharmacol. 13:1029636. PubMed
  44. Zhao X, et al. 2022. STAR Protoc. 3:101859. PubMed
  45. Chan L, et al. 2022. Cells. 12: . PubMed
  46. Ding D, et al. 2023. J Med Chem. 66:1467. PubMed
  47. Qin S, et al. 2023. Acta Pharm Sin B. :. PubMed
  48. Sun L, et al. 2023. Mol Med Rep. 27: . PubMed
  49. Di Benedetto C, et al. 2023. Cancers (Basel). 15: . PubMed
  50. Chan L, et al. 2023. Int J Mol Sci. 24: . PubMed
  51. Xiao JF, et al. 2022. Mol Cancer Res. 20:637. PubMed
  52. Shen JZ, et al. 2022. Mol Cell. 82:1123. PubMed
  53. Guo H, et al. 2022. Biomaterials. 283:121441. PubMed
  54. Zhang H, et al. 2022. J Exp Med. 219:. PubMed
  55. Bronge M, et al. 2022. Sci Adv. 8:eabn1823. PubMed
  56. Lentucci C, et al. 2017. J Biol Chem. 292:2754-2772. PubMed
  57. Glaser K, et al. 2015. Immunol Lett. 166: 19-27. PubMed
  58. Kusner L, et al. 2014. PLoS One. 9:102231. PubMed
  59. Khayrullina G, et al. 2020. Skelet Muscle. 10:16. PubMed
  60. Spitzer SO, et al. 2019. Neuron. 101:459. PubMed
  61. Li L,et al. 2017. Sci Rep.. 10.1038/s41598-017-14000-z. PubMed
  62. Li Q, et al. 2022. Cell Rep. 40:111308. PubMed
  63. van Vloten JP, et al. 2022. J Immunother Cancer. 10:. PubMed
  64. Lebedeva IV, et al. 2021. Cell Death Dis. 12:770. PubMed
  65. Zhang L, et al. 2021. J Immunol. 207:590. PubMed
  66. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  67. Zhang Y, et al. 2020. Oncol Lett. 1.053472222. PubMed
  68. Stewart CA, et al. 2020. bioRxiv. . PubMed
  69. Huang X, et al. 2019. Cancer Immunol Res. 1.388888889. PubMed
  70. Angiari S, et al. 2020. Cell Metab. 31:391. PubMed
  71. Jacob A, et al. 2020. Nature Protocols. 14(12):3303-3332.. PubMed
  72. Stewart CA, et al. 2021. J Thorac Oncol. Online ahead of prin. PubMed
  73. Kiritsy MC, et al. 2021. Elife. 10:. PubMed
  74. Poli V, et al. 2021. iScience. 24:103256. PubMed
  75. Duan Q, et al. 2021. Front Cell Dev Biol. 9:761193. PubMed
  76. Stegelmeier AA, et al. 2022. Biomedicines. 10:. PubMed
  77. Zhang S, et al. 2022. Cell Death Dis. 13:844. PubMed
  78. Haque M, et al. 2021. STAR Protoc. 2:100264. PubMed
  79. Martinez-Usatorre A, et al. 2020. Front Immunol. 11:340. PubMed
  80. Martinez–Usatorre A, et al. 2019. Cancer Immunol Res. 0.995138889. PubMed
  81. Goyal S, et al. 2017. Sci Rep. . 10.1038/s41598-017-18046-x. PubMed
  82. Tsai CY, et al. 2022. J Biomed Sci. 29:47. PubMed
  83. Gärtner F, et al. 2021. Front Immunol. 12:745132. PubMed
  84. Gao F, et al. 2021. Front Cell Infect Microbiol. 10:593805. PubMed
  85. Tang B, et al. 2020. Clin Cancer Res. 26:2216. PubMed
  86. Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed
  87. Eslani M,et al. 2017. Invest Ophthalmol Vis Sci.. 58(12):5507-5517. PubMed
  88. Shinde MY, et al. 2017. J Biol Chem. 292:18240. PubMed
  89. Haryadi L, et al. 2019. Vet World. 12:1529. PubMed
  90. Ghose J, et al. 2018. Oncoimmunology. 7:e1486948. PubMed
  91. Herda S, et al. 2021. Int J Cancer. 148:3097. PubMed
  92. Lau H, et al. 2021. Int J Mol Sci. 22:. PubMed
  93. Zhou H, et al. 2022. J Clin Invest. 132:. PubMed
  94. Zhang X, et al. 2020. J Immunol. 205:1743. PubMed
  95. Ni P, et al. 2014. J Immunol . 193:1778. PubMed
  96. Sohrabi Y, et al. 2020. Front Immunol. 11:353. PubMed
  97. Martinez–Usatorre A, et al. 2018. J Immunol. 201:792. PubMed
  98. Subham S, et al. 2022. Breast Cancer Res Treat. Online ahead of print. PubMed
  99. Lau H, et al. 2021. Xenotransplantation. 28:e12667. PubMed
  100. Su W, et al. 2022. Front Immunol. 13:952338. PubMed
  101. Ma Q, et al. 2022. Nat Commun. 13:4142. PubMed
  102. Datta A, et al. 2022. J Fungi (Basel). 8:. PubMed
  103. Jiang P, et al. 2021. Nat Methods. 18:1181. PubMed
  104. Zhan Y, et al. 2021. JCI Insight. 6:. PubMed
  105. Hendricks A, et al. 2021. Front Oncol. 11:646885. PubMed
  106. Shamsi F, et al. 2021. Nat Metab. 3:485. PubMed
  107. Xiao Z, et al. 2013. Mol Immunol. 56:423. PubMed
  108. Hilpert C, et al. 2016. J Immunol. 197: 2780 - 2786. PubMed
  109. Clancy–Thompson E, et al. 2018. Cancer Immunol Res. 1.308333333. PubMed
  110. Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed
  111. Zhang X, et al. 2022. Theranostics. 12:1621. PubMed
  112. Berical A, et al. 2022. Nat Commun. 13:4270. PubMed
  113. Pearce V, et al. 2015. J Immunol. 195: 3206 - 3217. PubMed
  114. Baek J, et al. 2017. Am J Pathol. 10.1016/j.ajpath.2017.02.011. PubMed
  115. Zhang L, et al. 2021. Methods Mol Biol. 2388:175. PubMed
  116. Rodriguez S, et al. 2020. Xenotransplantation. 27:e12554. PubMed
  117. Chakraborty S, et al. 2022. Sci Transl Med. . PubMed
  118. Leonard NA, et al. 2021. Cancers (Basel). 13:. PubMed
  119. Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed
  120. Lownik JC, et al. 2019. J Immunol. 202:664. PubMed
  121. Lau H, et al. 2020. Xenotransplantation. 27:e12555. PubMed
  122. Mkhikian H, et al. 2022. Nat Aging. 2:231. PubMed
  123. Li J, et al. 2022. J Tissue Eng. 13:20417314221127908. PubMed
  124. Ouyang W, et al. 2021. Invest Ophthalmol Vis Sci. 62:25:00. PubMed
  125. Nausch N, et al. 2017. PLoS Negl Trop Dis. 11(2):e0005415. PubMed
  126. Xu Z, et al. 2016. Nat Commun. 7:10728. PubMed
  127. Breznik JA, et al. 2018. Physiol Rep. 6:e13937. PubMed
  128. Ren Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  129. Wei W, et al. 2022. mSystems. 7:e0046922. PubMed
  130. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  131. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  132. Alvandi Z, et al. 2022. J Am Heart Assoc. 11:e023695. PubMed
  133. van Duijn A, et al. 2021. Cancer Immunol Immunother. Online ahead of print. PubMed
  134. Jakic B, et al. 2021. Cell Death Dis. 12:187. PubMed
  135. Li Q, et al. 2017. Front Immunol. 0.797916667. PubMed
  136. Page N, et al. 2021. Nat Commun. 12:1009. PubMed
  137. Gunasena M, et al. 2022. Sci Rep. 12:12377. PubMed
  138. Liu X, et al. 2016. Sci Rep. 6:36722. PubMed
  139. Rio M, et al. 2012. J Immunol. 188:4885. PubMed
  140. Kundu K, et al. 2019. Cancer Immunol Res. 1.069444444. PubMed
  141. Bajpai G, et al. 2018. Nat Med. 24:1234. PubMed
  142. Janela B, et al. 2019. Immunity. 50:1069. PubMed
  143. Wilmes A, et al. 2017. Toxicol In Vitro. 10.1016/j.tiv.2017.07.023. PubMed
  144. Hayes D, et al. 2022. JCI Insight. 7:. PubMed
  145. Gong C, et al. 2021. Mol Cell. 81:4059. PubMed
  146. Chen DL, et al. 2021. Mol Cancer. 20:166. PubMed
  147. Kim S, et al. 2020. Development. . PubMed
  148. Henrich IC, et al. 2021. Cancer Res. 81:2171. PubMed
  149. Rio M, et al. 2011. Transplantation. 92:1085. PubMed
  150. Chen YF, et al. 2019. J Biomed Sci. 26:85. PubMed
  151. Hiza H, et al. 2021. Sci Rep. 11:13190. PubMed
  152. Wen T, et al. 2022. Cancer Immunol Res. 10:162. PubMed
  153. Ma K, et al. 2022. iScience. 25:104347. PubMed
  154. Wang Y, et al. 2020. Virol Sin. 36:122. PubMed
  155. Lau H, et al. 2020. Islets. 41:12. PubMed
  156. Lau H, et al. 2020. PLoS One. 15:e0243506. PubMed
  157. Wang G, et al. 2020. Nat Commun. 0.611111111. PubMed
  158. Dong M, et al. 2022. J Immunother Cancer. 10:. PubMed
  159. Shemesh A, et al. 2022. J Exp Med. 219:. PubMed
  160. Teh MR, et al. 2021. Front Immunol. 12:714613. PubMed
  161. Haswell JR, et al. 2021. PLoS One. 16:e0252848. PubMed
  162. Park SR, et al. 2020. Cell Rep. 32:108077. PubMed
  163. Ansari M, et al. 2017. Cell Signal. 10.1016/j.cellsig.2017.04.014. PubMed
  164. Ahmad S, et al. 2017. Prog Neuropsychopharmacol Biol Psychiatry. 10.1016/j.pnpbp.2017.06.034. PubMed
  165. Xia Y, et al. 2018. Cell. 175:1059. PubMed
  166. Chen RH, et al. 2021. Front Immunol. 11:594775. PubMed
  167. Spiliopoulou P, et al. 2022. Mol Cancer Ther. . PubMed
  168. Tintos-Hernandez JA, et al. 2021. Brain Commun. 3:fcab215. PubMed
  169. Koutník J, et al. 2022. Cell Commun Signal. 20:54. PubMed
  170. Zhao X, et al. 2022. iScience. 25:104690. PubMed
  171. Cérbulo-Vázquez A, et al. 2022. PLoS One. 17:e0264566. PubMed
  172. Gao J, et al. 2022. Front Immunol. 13:955812. PubMed
  173. Lei L, et al. 2021. Front Cell Dev Biol. 659744:9. PubMed
  174. Frafjord A, et al. 2020. Scand J Immunol. e12889:92. PubMed
  175. Lownik JC, et al. 2020. Biochem Biophys Rep. 24:100803. PubMed
  176. Labi V, et al. 2019. Genes Dev. 33:1673. PubMed
  177. Sun X, et al. 2017. Microbes Infect. 10.1016/j.micinf.2017.08.007. PubMed
  178. Rhoades NS, et al. 2022. Cell Rep. 39:110725. PubMed
  179. Reuschl AK, et al. 2022. Cell Rep. 39:110650. PubMed
  180. Tatangelo V, et al. 2022. Front Oncol. 12:877495. PubMed
  181. Huang T, et al. 2022. Nat Commun. 13:3489. PubMed
  182. Deng Y, et al. 2021. Nat Commun. 12:7041. PubMed
  183. DiMuzio JM, et al. 2021. Vaccine X. 8:100098. PubMed
  184. Lee G, et al. 2021. Viruses. 13: . PubMed
  185. Hernandez AA, et al. 2020. J Immunol. 205:2806. PubMed
  186. Su Y, et al. 2020. Cell. 1479:183. PubMed
  187. Wawrzyniak M, et al. 2021. Pharmacol Res Perspect. 9:e00837. PubMed
  188. Mcgaw C, et al. 2022. Nat Commun. 13:2833. PubMed
  189. Wagner AK, et al. 2022. iScience. 25:105137. PubMed
  190. Zheng L, et al. 2020. Clin Cancer Res. 26:3694. PubMed
  191. Witt G, et al. 2020. Cell Biol Toxicol. . PubMed
  192. Marongiu L, et al. 2013. PLoS One. 8:75684. PubMed
  193. Giadone RM, et al. 2018. Amyloid. 25:148. PubMed
  194. Gebremeskel S, et al. 2017. Cancer Immunol Res. 0.9625. PubMed
  195. Sun Y, et al. 2022. iScience. 25:104846. PubMed
  196. van Loon K, et al. 2022. Cancers (Basel). 14:. PubMed
  197. Wang X, et al. 2022. Elife. 11:. PubMed
  198. Liu X, et al. 2021. Adv Sci (Weinh). 8:e2100233. PubMed
  199. Heckler M, et al. 2021. Cancer Discov. Online ahead of prin. PubMed
  200. Zhang Z, et al. 2021. Front Immunol. 12:699478. PubMed
  201. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  202. Chen Y, et al. 2021. Braz J Med Biol Res. 54:e9570. PubMed
  203. Xiao C, et al. 2021. STAR Protoc. 2:100789. PubMed
  204. Chen S, et al. 2020. Cancer Immunol Res. 1064:8. PubMed
  205. Assadi G, et al. 2016. PLoS One. 11:e0168276. PubMed
  206. Ikebuchi R, et al. 2016. Sci Rep. 6:35002. PubMed
  207. Lei F, et al. 2012. J Vis Exp. 63: 3986. PubMed
  208. Guo Z, et al. 2022. Neurobiol Pain. 12:100096. PubMed
  209. Luvanda MK, et al. 2021. J Fungi (Basel). 7:. PubMed
  210. Zhuo Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  211. Chen R, et al. 2022. J Mol Cell Biol. 14:. PubMed
  212. Tang J, et al. 2022. Sci Immunol. 7:eadd4853. PubMed
  213. Shen M, et al. 2022. Adv Sci (Weinh). 9:e2203523. PubMed
  214. Hajnik RL, et al. 2022. Sci Transl Med. 14:eabq1945. PubMed
  215. Frost JN, et al. 2022. Sci Adv. 8:eabq5384. PubMed
  216. Li L, et al. 2022. Cancer Immunol Res. 10:1475. PubMed
  217. Deák P, et al. 2022. Cell Rep. 41:111563. PubMed
  218. Stokes JV, et al. 2022. Curr Protoc. 2:e584. PubMed
  219. Jia DJ, et al. 2022. Gut Microbes. 14:2145843. PubMed
  220. Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed
  221. Kodama N, et al. 2023. Front Nutr. 10:1081263. PubMed
  222. Mohamed GA, et al. 2023. Breast Cancer Res. 25:23. PubMed
  223. Varun K, et al. 2023. EBioMedicine. 90:104516. PubMed
  224. Wang YH, et al. 2023. Int J Mol Sci. 24:. PubMed
  225. Deng G, et al. 2023. Cancers (Basel). 15:. PubMed
  226. Wang Y, et al. 2023. iScience. 26:106630. PubMed
  227. Changsheng H, et al. 2023. Sci Adv. 9:eade4186. PubMed
  228. Ruan H, et al. 2023. Acta Pharm Sin B. 13:2202. PubMed
  229. Zhang TR, et al. 2023. Pharmaceuticals (Basel). 16:. PubMed
  230. Komoto S, et al. 2023. Cancers (Basel). 15:. PubMed
  231. Li B, Schmidt N 2016. PLoS One. 11: 0162427. PubMed
  232. Darzianiazizi M, et al. 2020. Int J Mol Sci. 21:00. PubMed
  233. Kim S, et al. 2020. Development. 147:00:00. PubMed
  234. Dumauthioz N, et al. 2020. Cell Mol Immunol. . PubMed
  235. Rappazzo CG, et al. 2020. bioRxiv. . PubMed
  236. Hanga MP, et al. 2021. Biotechnol Bioeng. 118:3175. PubMed
  237. Arbues A, et al. 2020. PLoS Pathog. 16:e1008312. PubMed
  238. Kim J, et al. 2021. Cytometry A. 99:807. PubMed
  239. Sulaj A, et al. 2022. J Clin Endocrinol Metab. 107:2167. PubMed
  240. Brog RA, et al. 2022. Cancer Immunol Res. 10:962. PubMed
  241. Nozaki K, et al. 2022. Nature. 606:960. PubMed
  242. Shemesh A, et al. 2022. J Exp Med. 219: . PubMed
  243. Yin XY, et al. 2023. Neural Regen Res. 18:213. PubMed
  244. Blanas A, et al. 2022. iScience. 25:104719. PubMed
  245. Bates TA, et al. 2022. Cell Rep. 41:111544. PubMed
  246. Gong YY, et al. 2022. Cancer Res Commun. 2:842. PubMed
  247. Liang Y, et al. 2022. Theranostics. 12:7729. PubMed
  248. Wang Y, et al. 2022. Front Endocrinol (Lausanne). 13:1036517. PubMed
  249. Koutník J, et al. 2022. Front Immunol. 13:1049033. PubMed
  250. Minott JA, et al. 2022. Front Immunol. 13:1038340. PubMed
  251. Tan TCJ, et al. 2022. Nat Commun. 13:7796. PubMed
  252. Phares TW, et al. 2022. Front Pharmacol. 13:1029636. PubMed
  253. Zhao X, et al. 2022. STAR Protoc. 3:101859. PubMed
  254. Chan L, et al. 2022. Cells. 12: . PubMed
  255. Ding D, et al. 2023. J Med Chem. 66:1467. PubMed
  256. Qin S, et al. 2023. Acta Pharm Sin B. :. PubMed
  257. Sun L, et al. 2023. Mol Med Rep. 27: . PubMed
  258. Di Benedetto C, et al. 2023. Cancers (Basel). 15: . PubMed
  259. Chan L, et al. 2023. Int J Mol Sci. 24: . PubMed
  260. Xiao JF, et al. 2022. Mol Cancer Res. 20:637. PubMed
  261. Shen JZ, et al. 2022. Mol Cell. 82:1123. PubMed
  262. Guo H, et al. 2022. Biomaterials. 283:121441. PubMed
  263. Zhang H, et al. 2022. J Exp Med. 219:. PubMed
  264. Bronge M, et al. 2022. Sci Adv. 8:eabn1823. PubMed
  265. Lentucci C, et al. 2017. J Biol Chem. 292:2754-2772. PubMed
  266. Glaser K, et al. 2015. Immunol Lett. 166: 19-27. PubMed
  267. Kusner L, et al. 2014. PLoS One. 9:102231. PubMed
  268. Khayrullina G, et al. 2020. Skelet Muscle. 10:16. PubMed
  269. Spitzer SO, et al. 2019. Neuron. 101:459. PubMed
  270. Li L,et al. 2017. Sci Rep.. 10.1038/s41598-017-14000-z. PubMed
  271. Li Q, et al. 2022. Cell Rep. 40:111308. PubMed
  272. van Vloten JP, et al. 2022. J Immunother Cancer. 10:. PubMed
  273. Lebedeva IV, et al. 2021. Cell Death Dis. 12:770. PubMed
  274. Zhang L, et al. 2021. J Immunol. 207:590. PubMed
  275. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  276. Zhang Y, et al. 2020. Oncol Lett. 1.053472222. PubMed
  277. Stewart CA, et al. 2020. bioRxiv. . PubMed
  278. Huang X, et al. 2019. Cancer Immunol Res. 1.388888889. PubMed
  279. Angiari S, et al. 2020. Cell Metab. 31:391. PubMed
  280. Jacob A, et al. 2020. Nature Protocols. 14(12):3303-3332.. PubMed
  281. Stewart CA, et al. 2021. J Thorac Oncol. Online ahead of prin. PubMed
  282. Kiritsy MC, et al. 2021. Elife. 10:. PubMed
  283. Poli V, et al. 2021. iScience. 24:103256. PubMed
  284. Duan Q, et al. 2021. Front Cell Dev Biol. 9:761193. PubMed
  285. Stegelmeier AA, et al. 2022. Biomedicines. 10:. PubMed
  286. Zhang S, et al. 2022. Cell Death Dis. 13:844. PubMed
  287. Haque M, et al. 2021. STAR Protoc. 2:100264. PubMed
  288. Martinez-Usatorre A, et al. 2020. Front Immunol. 11:340. PubMed
  289. Martinez–Usatorre A, et al. 2019. Cancer Immunol Res. 0.995138889. PubMed
  290. Goyal S, et al. 2017. Sci Rep. . 10.1038/s41598-017-18046-x. PubMed
  291. Tsai CY, et al. 2022. J Biomed Sci. 29:47. PubMed
  292. Gärtner F, et al. 2021. Front Immunol. 12:745132. PubMed
  293. Gao F, et al. 2021. Front Cell Infect Microbiol. 10:593805. PubMed
  294. Tang B, et al. 2020. Clin Cancer Res. 26:2216. PubMed
  295. Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed
  296. Eslani M,et al. 2017. Invest Ophthalmol Vis Sci.. 58(12):5507-5517. PubMed
  297. Shinde MY, et al. 2017. J Biol Chem. 292:18240. PubMed
  298. Haryadi L, et al. 2019. Vet World. 12:1529. PubMed
  299. Ghose J, et al. 2018. Oncoimmunology. 7:e1486948. PubMed
  300. Herda S, et al. 2021. Int J Cancer. 148:3097. PubMed
  301. Lau H, et al. 2021. Int J Mol Sci. 22:. PubMed
  302. Zhou H, et al. 2022. J Clin Invest. 132:. PubMed
  303. Zhang X, et al. 2020. J Immunol. 205:1743. PubMed
  304. Ni P, et al. 2014. J Immunol . 193:1778. PubMed
  305. Sohrabi Y, et al. 2020. Front Immunol. 11:353. PubMed
  306. Martinez–Usatorre A, et al. 2018. J Immunol. 201:792. PubMed
  307. Subham S, et al. 2022. Breast Cancer Res Treat. Online ahead of print. PubMed
  308. Lau H, et al. 2021. Xenotransplantation. 28:e12667. PubMed
  309. Su W, et al. 2022. Front Immunol. 13:952338. PubMed
  310. Ma Q, et al. 2022. Nat Commun. 13:4142. PubMed
  311. Datta A, et al. 2022. J Fungi (Basel). 8:. PubMed
  312. Jiang P, et al. 2021. Nat Methods. 18:1181. PubMed
  313. Zhan Y, et al. 2021. JCI Insight. 6:. PubMed
  314. Hendricks A, et al. 2021. Front Oncol. 11:646885. PubMed
  315. Shamsi F, et al. 2021. Nat Metab. 3:485. PubMed
  316. Xiao Z, et al. 2013. Mol Immunol. 56:423. PubMed
  317. Hilpert C, et al. 2016. J Immunol. 197: 2780 - 2786. PubMed
  318. Clancy–Thompson E, et al. 2018. Cancer Immunol Res. 1.308333333. PubMed
  319. Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed
  320. Zhang X, et al. 2022. Theranostics. 12:1621. PubMed
  321. Berical A, et al. 2022. Nat Commun. 13:4270. PubMed
  322. Pearce V, et al. 2015. J Immunol. 195: 3206 - 3217. PubMed
  323. Baek J, et al. 2017. Am J Pathol. 10.1016/j.ajpath.2017.02.011. PubMed
  324. Zhang L, et al. 2021. Methods Mol Biol. 2388:175. PubMed
  325. Rodriguez S, et al. 2020. Xenotransplantation. 27:e12554. PubMed
  326. Chakraborty S, et al. 2022. Sci Transl Med. . PubMed
  327. Leonard NA, et al. 2021. Cancers (Basel). 13:. PubMed
  328. Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed
  329. Lownik JC, et al. 2019. J Immunol. 202:664. PubMed
  330. Lau H, et al. 2020. Xenotransplantation. 27:e12555. PubMed
  331. Mkhikian H, et al. 2022. Nat Aging. 2:231. PubMed
  332. Li J, et al. 2022. J Tissue Eng. 13:20417314221127908. PubMed
  333. Ouyang W, et al. 2021. Invest Ophthalmol Vis Sci. 62:25:00. PubMed
  334. Nausch N, et al. 2017. PLoS Negl Trop Dis. 11(2):e0005415. PubMed
  335. Xu Z, et al. 2016. Nat Commun. 7:10728. PubMed
  336. Breznik JA, et al. 2018. Physiol Rep. 6:e13937. PubMed
  337. Ren Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  338. Wei W, et al. 2022. mSystems. 7:e0046922. PubMed
  339. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  340. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  341. Alvandi Z, et al. 2022. J Am Heart Assoc. 11:e023695. PubMed
  342. van Duijn A, et al. 2021. Cancer Immunol Immunother. Online ahead of print. PubMed
  343. Jakic B, et al. 2021. Cell Death Dis. 12:187. PubMed
  344. Li Q, et al. 2017. Front Immunol. 0.797916667. PubMed
  345. Page N, et al. 2021. Nat Commun. 12:1009. PubMed
  346. Gunasena M, et al. 2022. Sci Rep. 12:12377. PubMed
  347. Liu X, et al. 2016. Sci Rep. 6:36722. PubMed
  348. Rio M, et al. 2012. J Immunol. 188:4885. PubMed
  349. Kundu K, et al. 2019. Cancer Immunol Res. 1.069444444. PubMed
  350. Bajpai G, et al. 2018. Nat Med. 24:1234. PubMed
  351. Janela B, et al. 2019. Immunity. 50:1069. PubMed
  352. Wilmes A, et al. 2017. Toxicol In Vitro. 10.1016/j.tiv.2017.07.023. PubMed
  353. Hayes D, et al. 2022. JCI Insight. 7:. PubMed
  354. Gong C, et al. 2021. Mol Cell. 81:4059. PubMed
  355. Chen DL, et al. 2021. Mol Cancer. 20:166. PubMed
  356. Kim S, et al. 2020. Development. . PubMed
  357. Henrich IC, et al. 2021. Cancer Res. 81:2171. PubMed
  358. Rio M, et al. 2011. Transplantation. 92:1085. PubMed
  359. Chen YF, et al. 2019. J Biomed Sci. 26:85. PubMed
  360. Hiza H, et al. 2021. Sci Rep. 11:13190. PubMed
  361. Wen T, et al. 2022. Cancer Immunol Res. 10:162. PubMed
  362. Ma K, et al. 2022. iScience. 25:104347. PubMed
  363. Wang Y, et al. 2020. Virol Sin. 36:122. PubMed
  364. Lau H, et al. 2020. Islets. 41:12. PubMed
  365. Lau H, et al. 2020. PLoS One. 15:e0243506. PubMed
  366. Wang G, et al. 2020. Nat Commun. 0.611111111. PubMed
  367. Dong M, et al. 2022. J Immunother Cancer. 10:. PubMed
  368. Shemesh A, et al. 2022. J Exp Med. 219:. PubMed
  369. Teh MR, et al. 2021. Front Immunol. 12:714613. PubMed
  370. Haswell JR, et al. 2021. PLoS One. 16:e0252848. PubMed
  371. Park SR, et al. 2020. Cell Rep. 32:108077. PubMed
  372. Ansari M, et al. 2017. Cell Signal. 10.1016/j.cellsig.2017.04.014. PubMed
  373. Ahmad S, et al. 2017. Prog Neuropsychopharmacol Biol Psychiatry. 10.1016/j.pnpbp.2017.06.034. PubMed
  374. Xia Y, et al. 2018. Cell. 175:1059. PubMed
  375. Chen RH, et al. 2021. Front Immunol. 11:594775. PubMed
  376. Spiliopoulou P, et al. 2022. Mol Cancer Ther. . PubMed
  377. Tintos-Hernandez JA, et al. 2021. Brain Commun. 3:fcab215. PubMed
  378. Koutník J, et al. 2022. Cell Commun Signal. 20:54. PubMed
  379. Zhao X, et al. 2022. iScience. 25:104690. PubMed
  380. Cérbulo-Vázquez A, et al. 2022. PLoS One. 17:e0264566. PubMed
  381. Gao J, et al. 2022. Front Immunol. 13:955812. PubMed
  382. Lei L, et al. 2021. Front Cell Dev Biol. 659744:9. PubMed
  383. Frafjord A, et al. 2020. Scand J Immunol. e12889:92. PubMed
  384. Lownik JC, et al. 2020. Biochem Biophys Rep. 24:100803. PubMed
  385. Labi V, et al. 2019. Genes Dev. 33:1673. PubMed
  386. Sun X, et al. 2017. Microbes Infect. 10.1016/j.micinf.2017.08.007. PubMed
  387. Rhoades NS, et al. 2022. Cell Rep. 39:110725. PubMed
  388. Reuschl AK, et al. 2022. Cell Rep. 39:110650. PubMed
  389. Tatangelo V, et al. 2022. Front Oncol. 12:877495. PubMed
  390. Huang T, et al. 2022. Nat Commun. 13:3489. PubMed
  391. Deng Y, et al. 2021. Nat Commun. 12:7041. PubMed
  392. DiMuzio JM, et al. 2021. Vaccine X. 8:100098. PubMed
  393. Lee G, et al. 2021. Viruses. 13: . PubMed
  394. Hernandez AA, et al. 2020. J Immunol. 205:2806. PubMed
  395. Su Y, et al. 2020. Cell. 1479:183. PubMed
  396. Wawrzyniak M, et al. 2021. Pharmacol Res Perspect. 9:e00837. PubMed
  397. Mcgaw C, et al. 2022. Nat Commun. 13:2833. PubMed
  398. Wagner AK, et al. 2022. iScience. 25:105137. PubMed
  399. Zheng L, et al. 2020. Clin Cancer Res. 26:3694. PubMed
  400. Witt G, et al. 2020. Cell Biol Toxicol. . PubMed
  401. Marongiu L, et al. 2013. PLoS One. 8:75684. PubMed
  402. Giadone RM, et al. 2018. Amyloid. 25:148. PubMed
  403. Gebremeskel S, et al. 2017. Cancer Immunol Res. 0.9625. PubMed
  404. Sun Y, et al. 2022. iScience. 25:104846. PubMed
  405. van Loon K, et al. 2022. Cancers (Basel). 14:. PubMed
  406. Wang X, et al. 2022. Elife. 11:. PubMed
  407. Liu X, et al. 2021. Adv Sci (Weinh). 8:e2100233. PubMed
  408. Heckler M, et al. 2021. Cancer Discov. Online ahead of prin. PubMed
  409. Zhang Z, et al. 2021. Front Immunol. 12:699478. PubMed
  410. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  411. Chen Y, et al. 2021. Braz J Med Biol Res. 54:e9570. PubMed
  412. Xiao C, et al. 2021. STAR Protoc. 2:100789. PubMed
  413. Chen S, et al. 2020. Cancer Immunol Res. 1064:8. PubMed
  414. Assadi G, et al. 2016. PLoS One. 11:e0168276. PubMed
  415. Ikebuchi R, et al. 2016. Sci Rep. 6:35002. PubMed
  416. Lei F, et al. 2012. J Vis Exp. 63: 3986. PubMed
  417. Guo Z, et al. 2022. Neurobiol Pain. 12:100096. PubMed
  418. Luvanda MK, et al. 2021. J Fungi (Basel). 7:. PubMed

Antigen Details

Antigen References

1. Current Protocols in Immunology (John Wiley & Sons New York) Unit 6.24 Detection of Intracellular Cytokines by Flow Cytometry (Barbara Foster and Calman Prussin NIAID NIH Bethesda MD).
2. Sander B, et al. 1991. Immunol. Rev. 119:65.
3. Sander B, et al. 1993. J. Immunol. Meth. 166:201.
4. Prussin C, et al. 1995. J. Immunol. Meth. 188:117.

Gene ID
NA
Go To Top Version: 3    Revision Date: 08/26/2015

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account